Market Overview

I think you’ll love what you hear,
what you’ll see and the opportunities
that will be set before you.
- Jon Najarian

UPDATE: BD Announces Divestment of Vertebral Augmentation Solutions Business to Stryker; Terms Not Disclosed


BD (Becton, Dickinson and Company) (NYSE: BDX), a leading medical technology company, announced today that it has sold its vertebral augmentation solutions business, which includes all AVAmax®, AVAflex®, AVAtex® and AVAprep® branded products to Stryker.

This sale will not have a material impact to revenue and earnings for fiscal 2016. Financial and contractual terms of the transaction were not disclosed.

Posted-In: News Asset Sales


Related Articles (BDX)

View Comments and Join the Discussion!

Inotek Pharma Reports Publication of Phase 1 Data for Trabodenoson in JOPT

The Bob Evans Sale-Leaseback Means Good Things For Bloomin' Brands